Bipartisan House Support Remains Elusive In 340B Reform Effort

Republicans continue to take the lead on advancing reforms, while Democrats warn proposals could endanger a government program supporting safety-net care.

Democrats Fear a New House On 340B Bill Goes Too Far. • Source: Shutterstock

The House Energy and Commerce Oversight and Investigations Subcommittee hearing on reforming the 340B outpatient drug discount program showcased the ongoing lack of broad bipartisan agreement on legislation addressing the issue.

Key Takeaways
  • Republicans and Democrats on the committee are not in alignment on how Congress should address possible reforms to the 340B drug discount program.

Over the past several years, Congress has taken incremental steps toward enhancing oversight of the program and clarifying its scope....

More from Pricing Debate

More from Market Access